Re-expansion pulmonary oedema (RPE) is an uncommon complication that occurs when a collapsed lung suddenly re-expands, resulting in an osmotic shift of fluid from the blood vessels into the air spaces ...
Scientists from Duke-NUS Medical School and their collaborators have identified an inherited genetic variation prevalent ...
Penumbra has developed a microprocessor with thrombus removal algorithms that, combined with audio-visual feedback, help ...
Penumbra (PEN) announced new data that demonstrate patients with intermediate-risk pulmonary embolism – PE – treated with ...
A nationwide retrospective study evaluated health care resource utilization and outcomes among patients with ...
8d
Findings from the first international randomized controlled trial to compare patient outcomes following treatment with ...
(Nasdaq:NARI) today announced positive results from its prospective PEERLESS trial for the FlowTriever system.
The trial adds much-needed randomized data to an area where it’s been lacking. Questions about methods muddy interpretation.
The FlowTriever system is 510(k)-Cleared by FDA and CE Mark approved for the treatment of pulmonary embolism and clot in transit in the right atrium. Inari Medical NewsMORE Related Stocks ...
Thrombolex announced findings from the RESCUE-II trial, which is evaluating the company’s Bashir endovascular catheter to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback